Zevia PBC (NYSE:ZVIA) CFO Girish Satya Sells 41,662 Shares of Stock

Zevia PBC (NYSE:ZVIAGet Free Report) CFO Girish Satya sold 41,662 shares of the company’s stock in a transaction on Wednesday, March 25th. The stock was sold at an average price of $1.18, for a total transaction of $49,161.16. Following the transaction, the chief financial officer owned 327,909 shares in the company, valued at approximately $386,932.62. The trade was a 11.27% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Zevia PBC Price Performance

ZVIA opened at $1.13 on Friday. Zevia PBC has a fifty-two week low of $1.11 and a fifty-two week high of $3.66. The firm has a market capitalization of $84.49 million, a PE ratio of -7.50 and a beta of 0.90. The company’s 50-day moving average is $1.55 and its 200 day moving average is $2.11.

Zevia PBC (NYSE:ZVIAGet Free Report) last issued its quarterly earnings data on Wednesday, February 25th. The company reported ($0.02) EPS for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.01. The firm had revenue of $37.87 million during the quarter, compared to analyst estimates of $39.96 million. Zevia PBC had a negative return on equity of 22.49% and a negative net margin of 6.15%. As a group, analysts expect that Zevia PBC will post -0.32 EPS for the current year.

Wall Street Analysts Forecast Growth

ZVIA has been the topic of a number of analyst reports. Telsey Advisory Group cut their price objective on shares of Zevia PBC from $6.00 to $5.00 and set an “outperform” rating on the stock in a report on Thursday, February 26th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Zevia PBC in a report on Wednesday, January 21st. Finally, Craig Hallum began coverage on shares of Zevia PBC in a research report on Thursday, January 15th. They set a “buy” rating and a $4.00 price target on the stock. Three research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $4.43.

Read Our Latest Report on ZVIA

Institutional Trading of Zevia PBC

Hedge funds have recently bought and sold shares of the business. Police & Firemen s Retirement System of New Jersey purchased a new position in Zevia PBC in the second quarter worth $25,000. Quadrature Capital Ltd purchased a new stake in shares of Zevia PBC during the 4th quarter valued at $26,000. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new stake in shares of Zevia PBC during the 4th quarter worth $27,000. Engineers Gate Manager LP purchased a new position in shares of Zevia PBC in the 4th quarter worth about $28,000. Finally, SG Americas Securities LLC purchased a new position in shares of Zevia PBC in the 4th quarter worth about $31,000. 53.21% of the stock is currently owned by institutional investors.

About Zevia PBC

(Get Free Report)

Zevia PBC, headquartered in Los Angeles, is a Public Benefit Corporation that produces zero-calorie, naturally sweetened beverages. Founded in 2007, the company went public through a merger with a special purpose acquisition company in March 2021. Zevia’s mission centers on offering healthier drink alternatives by using stevia leaf extract and other plant-based ingredients rather than sugar or artificial sweeteners.

The company’s product portfolio spans multiple categories, including carbonated sodas, sparkling water, energy drinks, mixers and flavored teas.

Featured Articles

Receive News & Ratings for Zevia PBC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zevia PBC and related companies with MarketBeat.com's FREE daily email newsletter.